Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Central insulin action in energy and glucose homeostasis
Leona Plum, … , Bengt F. Belgardt, Jens C. Brüning
Leona Plum, … , Bengt F. Belgardt, Jens C. Brüning
Published July 3, 2006
Citation Information: J Clin Invest. 2006;116(7):1761-1766. https://doi.org/10.1172/JCI29063.
View: Text | PDF
Review Series

Central insulin action in energy and glucose homeostasis

  • Text
  • PDF
Abstract

Insulin has pleiotropic biological effects in virtually all tissues. However, the relevance of insulin signaling in peripheral tissues has been studied far more extensively than its role in the brain. An evolving body of evidence indicates that in the brain, insulin is involved in multiple regulatory mechanisms including neuronal survival, learning, and memory, as well as in regulation of energy homeostasis and reproductive endocrinology. Here we review insulin’s role as a central homeostatic signal with regard to energy and glucose homeostasis and discuss the mechanisms by which insulin communicates information about the body’s energy status to the brain. Particular emphasis is placed on the controversial current debate about the similarities and differences between hypothalamic insulin and leptin signaling at the molecular level.

Authors

Leona Plum, Bengt F. Belgardt, Jens C. Brüning

×

Figure 2

Generation of PIP3 leads to KATP channel opening and consecutive cell hyperpolarization.

Options: View larger image (or click on image) Download as PowerPoint

                  Generation of PIP3
                  leads to KATP
  ...
Insulin activates PI3K, which phosphorylates PIP2 on position 3′ in the inositol ring, generating PIP3. The lipid phosphatase PTEN antagonizes this by dephosphorylating PIP3 to generate PIP2. PIP3 accumulation leads to activation of KATP channels and, thus, to potassium outflow. This leads to membrane hyperpolarization and silencing of the neuron. Three different mechanisms for channel opening have been suggested: (i) PIP3 binding to the Kir6.2 subunit of the potassium channel increases the probability that the channel is open, which indirectly lowers inhibition by ATP; (ii) PIP3 competes with ATP for binding to the Kir6.2 subunit, thereby lowering ATP’s ability to close the channel; and (iii) PIP3 activates degradation of the local actin cytoskeleton. Also, activation of proteins downstream in the insulin cascade such as PDK1, AKT, glycogen synthase kinase 3 (GSK3), or mammalian target of rapamycin (mTOR) may be involved in insulin’s ability to regulate KATP channel opening.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts